Literature DB >> 27786237

Pharmacotherapy: Current role of β-blockers after MI in patients without HF.

Debabrata Mukherjee1, Kim A Eagle2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27786237     DOI： 10.1038/nrcardio.2016.176

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  10 in total

1.  2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff
Journal:  Circulation       Date:  2013-06-05       Impact factor: 29.690

2.  Early intravenous beta-blockers in patients with acute coronary syndrome--a meta-analysis of randomized trials.

Authors:  Saurav Chatterjee; Debanik Chaudhuri; Rajesh Vedanthan; Valentin Fuster; Borja Ibanez; Sripal Bangalore; Debabrata Mukherjee
Journal:  Int J Cardiol       Date:  2012-11-17       Impact factor: 4.164

3.  2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Ezra A Amsterdam; Nanette K Wenger; Ralph G Brindis; Donald E Casey; Theodore G Ganiats; David R Holmes; Allan S Jaffe; Hani Jneid; Rosemary F Kelly; Michael C Kontos; Glenn N Levine; Philip R Liebson; Debabrata Mukherjee; Eric D Peterson; Marc S Sabatine; Richard W Smalling; Susan J Zieman
Journal:  J Am Coll Cardiol       Date:  2014-09-23       Impact factor: 24.094

Review 4.  Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction.

Authors:  S Yusuf; J Wittes; L Friedman
Journal:  JAMA       Date:  1988-10-14       Impact factor: 56.272

5.  Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study.

Authors:  R Roberts; W J Rogers; H S Mueller; C T Lambrew; D J Diver; H C Smith; J T Willerson; G L Knatterud; S Forman; E Passamani
Journal:  Circulation       Date:  1991-02       Impact factor: 29.690

6.  Clinical outcomes with β-blockers for myocardial infarction: a meta-analysis of randomized trials.

Authors:  Sripal Bangalore; Harikrishna Makani; Martha Radford; Kamia Thakur; Bora Toklu; Stuart D Katz; James J DiNicolantonio; P J Devereaux; Karen P Alexander; Jorn Wetterslev; Franz H Messerli
Journal:  Am J Med       Date:  2014-06-11       Impact factor: 4.965

7.  Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry.

Authors:  Apurva A Motivala; Valay Parikh; Matthew Roe; David Dai; J Dawn Abbott; Abhiram Prasad; Debabrata Mukherjee
Journal:  JACC Cardiovasc Interv       Date:  2016-08-22       Impact factor: 11.195

8.  Effect of carvedilol on survival in severe chronic heart failure.

Authors:  M Packer; A J Coats; M B Fowler; H A Katus; H Krum; P Mohacsi; J L Rouleau; M Tendera; A Castaigne; E B Roecker; M K Schultz; D L DeMets
Journal:  N Engl J Med       Date:  2001-05-31       Impact factor: 91.245

9.  2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).

Authors:  Marco Roffi; Carlo Patrono; Jean-Philippe Collet; Christian Mueller; Marco Valgimigli; Felicita Andreotti; Jeroen J Bax; Michael A Borger; Carlos Brotons; Derek P Chew; Baris Gencer; Gerd Hasenfuss; Keld Kjeldsen; Patrizio Lancellotti; Ulf Landmesser; Julinda Mehilli; Debabrata Mukherjee; Robert F Storey; Stephan Windecker
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

10.  β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study.

Authors:  Etienne Puymirat; Elisabeth Riant; Nadia Aissaoui; Angèle Soria; Gregory Ducrocq; Pierre Coste; Yves Cottin; Jean François Aupetit; Eric Bonnefoy; Didier Blanchard; Simon Cattan; Gabriel Steg; François Schiele; Jean Ferrières; Yves Juillière; Tabassome Simon; Nicolas Danchin
Journal:  BMJ       Date:  2016-09-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.